Fenofibric acid

非诺贝特酸

Report date: 2026/05/13 20:02:10
NME

Base Information

Drug NameFenofibric acid
Drug Alias NameFenofibrate acid盐酸非诺贝特非诺贝酸Fenofibratum acidFenofibrato acid +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsHypertriglyceridemiaHypercholesterolemiaHyperlipidemias +[4] 
Global Approved IndicationsHypertriglyceridemiaHypercholesterolemiaHyperlipidemias +[4] 
Approved Indications in ChinaHypertriglyceridemiaHypercholesterolemia
Original Approved Country/TerritoryUnited States
Original Approved Date2009/08/14
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co LtdSabal Therapeutics LLCChangchun Haiyue Pharmaceutical Limited By Share Ltd
Inactive CompaniesAbbott LaboratoriesRosemont Pharmaceuticals LtdFournier Laboratories Ireland Ltd +[4] 
Active IndicationsHypertriglyceridemiaHypercholesterolemiaHyperlipidemias
Inactive IndicationsDyslipidemias

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG